（Fund9’s portfolio）

Scala Biodesign provides a unique one-shot computational solution that accelerates the development of proteins into commercial products.Scala’s technologies, developed by its founding team at the Weizmann Institute of Science, are backed by an unprecedented record of over 130 peer-reviewed publications and collaborations with 80 commercial and academic partners. Scala has partnered with some of the largest pharma and chemical corporations worldwide and its technology has successfully overcome development challenges that confounded expert teams for years.